730 related articles for article (PubMed ID: 18510696)
1. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.
Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H
Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696
[TBL] [Abstract][Full Text] [Related]
2. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation.
van Neerven RJ; Arvidsson M; Ipsen H; Sparholt SH; Rak S; Würtzen PA
Clin Exp Allergy; 2004 Mar; 34(3):420-8. PubMed ID: 15005736
[TBL] [Abstract][Full Text] [Related]
4. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation.
van Neerven RJ; Wikborg T; Lund G; Jacobsen B; Brinch-Nielsen A; Arnved J; Ipsen H
J Immunol; 1999 Sep; 163(5):2944-52. PubMed ID: 10453043
[TBL] [Abstract][Full Text] [Related]
5. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
6. Serum-IgE-facilitated allergen presentation in atopic disease.
van der Heijden FL; Joost van Neerven RJ; van Katwijk M; Bos JD; Kapsenberg ML
J Immunol; 1993 Apr; 150(8 Pt 1):3643-50. PubMed ID: 8468493
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
[TBL] [Abstract][Full Text] [Related]
8. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy.
Mittag D; Akkerdaas J; Ballmer-Weber BK; Vogel L; Wensing M; Becker WM; Koppelman SJ; Knulst AC; Helbling A; Hefle SL; Van Ree R; Vieths S
J Allergy Clin Immunol; 2004 Dec; 114(6):1410-7. PubMed ID: 15577846
[TBL] [Abstract][Full Text] [Related]
9. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.
van Neerven RJ; Knol EF; Ejrnaes A; Würtzen PA
Int Arch Allergy Immunol; 2006; 141(2):119-29. PubMed ID: 16864979
[TBL] [Abstract][Full Text] [Related]
10. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
[TBL] [Abstract][Full Text] [Related]
11. Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity.
Holm J; Willumsen N; Würtzen PA; Christensen LH; Lund K
J Allergy Clin Immunol; 2011 Apr; 127(4):1029-37. PubMed ID: 21377718
[TBL] [Abstract][Full Text] [Related]
12. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
Wilcock LK; Francis JN; Durham SR
Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
[TBL] [Abstract][Full Text] [Related]
13. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
Grindebacke H; Wing K; Andersson AC; Suri-Payer E; Rak S; Rudin A
Clin Exp Allergy; 2004 Sep; 34(9):1364-72. PubMed ID: 15347368
[TBL] [Abstract][Full Text] [Related]
14. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
[TBL] [Abstract][Full Text] [Related]
15. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.
Kopp MV; Stenglein S; Kamin W; Friedrichs F; von Berg A; Zielen S; Hamelmann E; Wahn U; Kuehr J
Pediatr Allergy Immunol; 2007 Sep; 18(6):523-7. PubMed ID: 17680911
[TBL] [Abstract][Full Text] [Related]
16. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
Hylander T; Latif L; Petersson-Westin U; Cardell LO
J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
[TBL] [Abstract][Full Text] [Related]
17. Food allergy to apple and specific immunotherapy with birch pollen.
Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
[TBL] [Abstract][Full Text] [Related]
18. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
Hessel EM; Chu M; Lizcano JO; Chang B; Herman N; Kell SA; Wills-Karp M; Coffman RL
J Exp Med; 2005 Dec; 202(11):1563-73. PubMed ID: 16314434
[TBL] [Abstract][Full Text] [Related]
19. Isotypic analysis of grass pollen-specific antibodies in human plasma. 4. Biological activity of allergen-specific and autoanti-IgE antibody fractions on basophil histamine release.
Batard T; Weyer A; Laroze A; Ickovic MR; David B; Peltre G; Basuyaux B
Clin Exp Allergy; 1996 Nov; 26(11):1308-15. PubMed ID: 8955580
[TBL] [Abstract][Full Text] [Related]
20. IgG antibodies in food allergy influence allergen-antibody complex formation and binding to B cells: a role for complement receptors.
Meulenbroek LA; de Jong RJ; den Hartog Jager CF; Monsuur HN; Wouters D; Nauta AJ; Knippels LM; van Neerven RJ; Ruiter B; Leusen JH; Hack CE; Bruijnzeel-Koomen CA; Knulst AC; Garssen J; van Hoffen E
J Immunol; 2013 Oct; 191(7):3526-33. PubMed ID: 23997216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
